ALIZA GABAY: Open Payments
NPI 1558863712 · FAIR LAWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,273 in 74 payments from 13 companies in 2025. Trend: 2023 $813 · 2024 $1,265 · 2025 $1,273
Food & beverage: $1,273
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $521 |
| Amgen Inc. | 8 | $141 |
| Novartis Pharmaceuticals Corporation | 6 | $132 |
| Regeneron Healthcare Solutions, Inc. | 6 | $108 |
| Arcutis Biotherapeutics, Inc. | 5 | $78 |
| Botanix SB Inc | 4 | $72 |
| Galderma Laboratories, L.P. | 4 | $67 |
| UCB, Inc. | 2 | $34 |
| LEO Pharma Inc. | 2 | $33 |
| PFIZER INC. | 2 | $31 |
Products named: RINVOQ, SKYRIZI, OTEZLA, COSENTYX, DUPIXENT, Zoryve, SOFDRA, Bimzelx.
Industry payments across NJ — which companies pay providers there.
